Erin Park, MS, DO

My first sub-i and my #1 choice, see you soon @LRHGME_GS @LRHGME 🔪👩🏻‍⚕️

Another year for the girlys AND the DO’s 🎉

“eres estúpida” literalmente yo:

If your attending isn’t texting you like this then wyd

Me scrolling through Match day

I JUST WANT EVERYONE TO MATCH

because im in residency

Everybody always talking about “GLP-1 this” and “GLP-1 that” Only the real OGs know the real GLP-1 lore

When the MICU attending asks if you’re on call every night because she only sees my name on the schedule 😅

This International Women's Day, we honor Alison Ann Clarey, D.O., FACOS - a trailblazing surgeon, educator, and leader who paved the way for women in surgery. In 1977, she became Dayton, Ohio’s first female surgeon and the first female resident at Grandview Hospital, later founding its bariatric surgery program. As Program Director of the General Surgery Residency, she mentored generations of surgeons, earning respect through her excellence in the OR. Dr. Clarey extended her care beyond borders, providing free surgical care locally and volunteering in Sierra Leone, Madagascar, Romania, and Guatemala, earning her the ACOS Humanitarian Award. She made history as the first woman President of the American College of Osteopathic Surgeons (ACOS) in 2007 and led the Ohio Osteopathic Association as President during its centennial year. In recognition of her exceptional leadership and contributions to the profession, she received the ACOS Orel F. Martin Medal in 2010. Dr. Clarey passed in 2011 after a courageous battle with breast cancer, through her legacy lives on. As ACOS celebrates its 100th anniversary in 2027 and the 20th anniversary of Dr. Clarey’s historic presidency, we reflect on the influence of her mentorship, leadership, and dedication which continues to be felt across the profession today. Take a look through some of Dr. Clarey's incredible history from ACOS News.

@MedStudentMcGee I made my PCP get all these labs and she was like “maybe you’re stressed” 😂😂😂

@eringpark I’m losing hair and breaking out so bad 😭 hopefully confirmation bias

One year ago, I was losing so much hair over Match Week that my wedding planner asked if we had to prepare for extensions Now I have curtain-length bangs that everyone thinks I did on purpose 💇‍♀️ It gets better, I swear

Me watching the clock go from 1:59 to 3:00am

this was my 1 night off...... can't talk rn

🧵 Rectal cancer is not one disease. Tumor location should shape treatment. A new JCO review argues that low- and mid-rectal cancers need different neoadjuvant strategies, with major implications for organ preservation, RT use, and QoL. 📍 Low-rectal cancers Goal: maximize cCR and preserve organ/sphincter whenever safely possible Relevant trials: RAPIDO, STELLAR, PRODIGE 23, OPRA, CAO/ARO/AIO-12 💡 Takeaway: TNT is often the preferred platform when the priority is watch-and-wait / organ preservation. 📍 Mid-rectal cancers Goal: avoid overtreatment, especially unnecessary pelvic RT in selected patients Relevant trials: PROSPECT, CONVERT, FOWARC, GRECCAR4 💡 Takeaway: In MRI-favorable, selected mid-rectal tumors, chemo-first or chemo-alone strategies may reduce long-term bowel, urinary, and sexual toxicity without compromising outcomes. 🎯 Organ preservation evidence base OPRA supports consolidation-based TNT for better TME-free survival. GRECCAR2, ACOSOG Z6041, OPERA reinforce that selected good responders may avoid radical surgery. Bottom line: Low rectum = intensify for cCR Mid rectum = de-escalate when safe That is the real shift toward precision rectal cancer care. 🔖 📖 Full paper in comment ⬇️ #OncoTwitter #MedTwitter #RectalCancer #ColorectalCancer @OncoAlert @ASCO @myESMO

Shoutout to the ED nurse that gave me my prophylactic Rocephin injection tonight, bonded forever at this point 😂

Check out our most recent project and publication! A case report of carcinoid tumor presenting as choledocholithiasis: An uncommon culprit in a common crime - ScienceDirect sciencedirect.com/science/articl…

Systematic review and meta-analysis: Prophylactic TXA use was associated with lower intraoperative blood loss, transfusion requirements, and major bleeding without an observed increase in thromboembolic or mortality risk. ja.ma/4c8OJZU

when the exam is so hard you’re learning new things by reading the questions